Page last updated: 2024-10-22

amsacrine and Hypokalemia

amsacrine has been researched along with Hypokalemia in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mittelman, A1
Arlin, ZA1

Other Studies

1 other study available for amsacrine and Hypokalemia

ArticleYear
AMSA-induced seizures in patients with hypokalemia.
    Cancer treatment reports, 1983, Volume: 67, Issue:1

    Topics: Aminoacridines; Amsacrine; Female; Humans; Hypokalemia; Leukemia; Middle Aged; Seizures

1983